Member Info for Timster

Only 3 weeks till the 21st, can't wait.

..

Twat

It's fairly obvious why, it's the golden cross, and it's a bullish one.

Not sure if that trumps a death spiral though.

Thanks energyshares, Fiona appears to know what she's doing, absolute shocker.....

Best thing today is email avacta to save them from looking stupid. Let us know if Al thanks you.

I am 100% sure that you are much cleverer than all the lead investigators in the UK and the US. You will be several steps ahead of all the pretend scientists. Well done eggy you are the greatest..... 😍

This the sort of thing your after

A FAP PET imaging study assessed the FAP expression of 28 different kinds of cancer by using PET/CT imaging to detect the amount of 68Ga-FAPI tracer uptake by each type of cancer. The results are expressed as Standardized Uptake Values (SUV).

I'll let you Google it, I believe fap imaging was mentioned again in the AGM.

Moron I think would be a suitable pronoun.

You are one absolute weirdo eggy.

CEO says there's a paradigm shift coming, safety committee recommends another increase in dosage. FDA approve a change in phase 2 design, the tumour type that ava6000 will target (STS) shows a significant reduction in a phase 1a safety and tolerability trial.who should we pay attention to.... Now let me think....

We know it's likely to come in Q4 from all the available information.

We also know that it's collated already and just being QA'd could come any day.

Interestingly though would they risk adding Cohort 7 data as a late addition, with extra time for QA? Depends if it completes soon I guess.

I just hope the data has arthritis covered....

"The data baselines the platform validation and unequivocally exposes the tech’s potential."

Absolutely BITL, it's the game changer.

What if the data is awful though?

It's not like we've had any clues in over a year of clinical trial administering double the dose of dox and seeing significant reduction in tumour size of an STS patient. With minimal side effects and an excellent safety and tolerability profile. Sating as fact that the pre|CISION platform works.

All just words....

Incredible news for Avacta...

It's an eggy made up problem BV

I think they might have had to rns a NASDAQ listing.

No, they can only use off patent drugs as far as I understand it.

But it presents a huge opportunity for companies that have drugs that are very effective but also highly toxic and would benefit hugely from local targeting (obviously Thier targets would have to be fap rich environments)

You've used the old, "not a deramp, but..." Line a few times there.

Got bored after the first paragraph (at least you used paragraphs)

What are you trying to say?

Good luck with your investment can't go wrong with Avacta, pre|CISION works that's the only headline we need.

Very good point PL75 FDA approval fo the 2 week study of highly toxic chemo that patients normally need weeks to recover from will be a massive tick in the box on the way to approval.

Absolutely incredible is Fiona and Al can continue to pull the wool over the FDA'S eyes with their scam chemo without side effects drug.

considering the weeks following the hci share issues are normally ****e. to be up a few percent is very good and the volume had been high, i know, i know you are all thinking it's down to esmo last weekend.

cohort 7 news could be relatively close, phase 1a data we know is being qa'd november could be the transformative month we've all (apart from eggy and 🐶💩🪨🦷) been waiting for.